Approvals/CIMA-AEMPS/XENPOZYME 4 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

XENPOZYME 4 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Sanofi B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: b92c36ca0ff253b9
Drug Cima Aemps Name: XENPOZYME 4 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1221659005
Holder Company Name: Sanofi B.V.
Marketing Company Name: Sanofi Aventis S.A.
Holder Company Detail Path: /organization/sanofi-b-v
Authorization Date: 2023-05-04
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 4 MG
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Sanofi B.V.
Company Detail Path: /organization/sanofi-b-v

OLIPUDASA ALFA

4 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 4, 2023

Approval ID

b92c36ca0ff253b9

Type

Standard